Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 7—July 2023
Research

Triplex ELISA for Assessing Durability of Taenia solium Seropositivity after Neurocysticercosis Cure

Nina L. Tang, Theodore E. Nash, Madelynn Corda, Thomas B. Nutman, and Elise M. O’ConnellComments to Author 
Author affiliation: National Institutes of Health, Bethesda, Maryland, USA

Main Article

Figure 5

Odds ratios of seropositivity of a triplex assay to determine durability of Taenia solium seropositivity after neurocysticercosis cure. The assay combines 3 families of T. solium antigens: T24H, GP50, and Ts18var3. We assessed seropositivity in extraparenchymal and parenchymal disease. Error bars indicate 95% CIs; arrows indicate that the end of a CI exceeds the range of the graph axis. NCC, neurocysticercosis; 1/OR, reciprocal odds ratio; OR, odds ratio.

Figure 5. Odds ratios of seropositivity of a triplex assay to determine durability of Taenia solium seropositivity after neurocysticercosis cure. The assay combines 3 families of T. solium antigens: T24H, GP50, and Ts18var3. We assessed seropositivity in extraparenchymal and parenchymal disease. Error bars indicate 95% CIs; arrows indicate that the end of a CI exceeds the range of the graph axis. NCC, neurocysticercosis; 1/OR, reciprocal odds ratio; OR, odds ratio.

Main Article

Page created: May 08, 2023
Page updated: June 20, 2023
Page reviewed: June 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external